FindTrial
Sign In

Impact of intravenous indocyanine green injection on bile duct cannulation during endoscopic retrograde cholangiopancreatography

Impact of intravenous indocyanine green injection on bile duct cannulation during endoscopic retrograde cholangiopancreatography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050273
Enrollment
Unknown
Registered
2021-08-25
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic retrograde cholangiopancreatography

Interventions

Case series:Intravenous indocyanine green injection

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18 to 80 years; 2.ERCP should be treated for various reasons; 3.Intact native papilla; 4.First time undergoing ERCP; 5.Normal serum amylase level before ERCP.

Exclusion criteria

Exclusion criteria: 1.Severe heart and lung disease, severe renal insufficiency; 2.Pregnancy; 3.Active acute pancreatitis, evidence of severe chronic pancreatitis; 4.Altered gastrointestinal tract anatomy; 5.Patients who refuse to participate in this study.

Design outcomes

Primary

MeasureTime frame
cannulation success rate;intubation and fluoroscopy times;post-ERCP pancreatitis;perforation;—

Secondary

MeasureTime frame
deep cholangetic cannulation time;postoperative hyperamylasemia;number of pancreatic duct strays;whether or not to perform a nipple preresection;time required for intubation;—

Countries

China

Contacts

Public ContactZhao Qiu

Zhongnan Hospital of Wuhan University

zhaoqiu@163.com+86 13761491681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026